Hi Kip, Thanks for the update. This should have really been included in the Shareholder Report. Not only for existing shareholders but for those new to Suda. By choosing not to make some mention does give cause for concern.
It would have also been nice to see a mention of how things were progressing with "Anagrelide" and if they are on track to complete DD in the six months indicated. This could actually be a huge windfall for Suda if the delivery method is proven successful.
GO THE EAGLES!!!
prescription medicine registration process, page-14
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
0.005(3.57%) |
Mkt cap ! $152.5M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 14.5¢ | 14.0¢ | $212.8K | 1.496M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 435513 | 14.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.5¢ | 9923 | 1 |
View Market Depth
| Last trade - 15.45pm 06/08/2024 (20 minute delay) ? |
| ALA (ASX) Chart |